ETS1 and renal cell carcinoma: Moreover, Kaplan–Meier survival analysis from the TCGA RCC dataset showed that RCC patients with low ETS1 expression had longer survival times than patients with high ETS1 expression levels (log-rank test, p < 0.05, Fig. 5h, Table S15), in keeping with the same analysis from the Human Protein Atlas (https://www.proteinatlas.org/) (Figure S1H).